MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)

Clinical trial NCT06455826 · COMPLETED

Trial details

NCT number: NCT06455826
Sponsor: PYC Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Retinitis Pigmentosa 11 Retinal Degeneration Eye Diseases Retinal Disease Retinal Dystrophies

Start date: 2024-06-13
Primary completion: 2025-09-24
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.